GB9826180D0 - Novel process - Google Patents

Novel process

Info

Publication number
GB9826180D0
GB9826180D0 GBGB9826180.3A GB9826180A GB9826180D0 GB 9826180 D0 GB9826180 D0 GB 9826180D0 GB 9826180 A GB9826180 A GB 9826180A GB 9826180 D0 GB9826180 D0 GB 9826180D0
Authority
GB
United Kingdom
Prior art keywords
novel process
novel
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB9826180.3A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SmithKline Beecham Ltd
Original Assignee
SmithKline Beecham Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SmithKline Beecham Ltd filed Critical SmithKline Beecham Ltd
Priority to GBGB9826180.3A priority Critical patent/GB9826180D0/en
Publication of GB9826180D0 publication Critical patent/GB9826180D0/en
Priority to AU13978/00A priority patent/AU1397800A/en
Priority to EP99973026A priority patent/EP1135382A1/en
Priority to JP2000585235A priority patent/JP2002531451A/en
Priority to PCT/GB1999/003992 priority patent/WO2000032593A1/en
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/14—Drugs for dermatological disorders for baldness or alopecia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/32—Alcohol-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Diabetes (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Endocrinology (AREA)
  • Addiction (AREA)
  • Child & Adolescent Psychology (AREA)
  • Emergency Medicine (AREA)
  • Rheumatology (AREA)
  • Hospice & Palliative Care (AREA)
  • Dermatology (AREA)
  • Reproductive Health (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
GBGB9826180.3A 1998-11-30 1998-11-30 Novel process Ceased GB9826180D0 (en)

Priority Applications (5)

Application Number Priority Date Filing Date Title
GBGB9826180.3A GB9826180D0 (en) 1998-11-30 1998-11-30 Novel process
AU13978/00A AU1397800A (en) 1998-11-30 1999-11-30 Method of producing paroxetine hydrochloride
EP99973026A EP1135382A1 (en) 1998-11-30 1999-11-30 Method of producing paroxetine hydrochloride
JP2000585235A JP2002531451A (en) 1998-11-30 1999-11-30 Preparation of paroxetine hydrochloride
PCT/GB1999/003992 WO2000032593A1 (en) 1998-11-30 1999-11-30 Method of producing paroxetine hydrochloride

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9826180.3A GB9826180D0 (en) 1998-11-30 1998-11-30 Novel process

Publications (1)

Publication Number Publication Date
GB9826180D0 true GB9826180D0 (en) 1999-01-20

Family

ID=10843292

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB9826180.3A Ceased GB9826180D0 (en) 1998-11-30 1998-11-30 Novel process

Country Status (5)

Country Link
EP (1) EP1135382A1 (en)
JP (1) JP2002531451A (en)
AU (1) AU1397800A (en)
GB (1) GB9826180D0 (en)
WO (1) WO2000032593A1 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9923446D0 (en) * 1999-10-04 1999-12-08 Smithkline Beecham Plc Novel process
IL159280A0 (en) * 2001-06-14 2004-06-01 Teva Pharma A process for preparing paroxetine hcl which limits formation of pink colored compounds
US7396542B2 (en) 2001-12-28 2008-07-08 Teva Pharmaceutical Industries Ltd. Stable pharmaceutical formulation of paroxetine hydrochloride anhydrous and a process for preparation thereof
CA2496726A1 (en) * 2002-09-19 2004-04-01 Sumitomo Chemical Company, Limited Methods of crystal precipitation
MY140618A (en) 2003-02-28 2009-12-31 Kowa Co Method for preparing acid addition salts of polyacidic basic compounds
DE602006002650D1 (en) * 2005-05-26 2008-10-23 Apotecnia S A Process for the preparation of paroxetine hydrochloride hemihydrate

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2058061T3 (en) * 1985-10-25 1994-11-01 Beecham Group Plc DERIVED FROM PIPERIDINE, ITS PREPARATION AND ITS USE AS A MEDICINAL PRODUCT.
AR001982A1 (en) * 1995-02-06 1998-01-07 Smithkline Beecham Plc PAROXETINE CHLORHYDRATE ANHYDRATED, AND PROCEDURE FOR ITS PREPARATION
CA2206592A1 (en) * 1996-05-30 1997-11-30 Shu-Zhong Wang Method of producing amorphous paroxetine hydrochloride
HU221921B1 (en) * 1996-07-08 2003-02-28 Richter Gedeon Vegyészeti Gyár Rt. N-benzyl-piperidine or tetrahydro-pyridine derivatives and processes for producing them
US5672612A (en) * 1996-09-09 1997-09-30 Pentech Pharmaceuticals, Inc. Amorphous paroxetine composition

Also Published As

Publication number Publication date
WO2000032593A1 (en) 2000-06-08
AU1397800A (en) 2000-06-19
EP1135382A1 (en) 2001-09-26
JP2002531451A (en) 2002-09-24

Similar Documents

Publication Publication Date Title
GB0106312D0 (en) Process
GB9816385D0 (en) Process
EP1127060A4 (en) Hydroboronation process
GB9827387D0 (en) Novel process
GB9826180D0 (en) Novel process
GB9826242D0 (en) Novel process
GB9816564D0 (en) Process
GB9806527D0 (en) Process
GB9824298D0 (en) Novel process
GB9826175D0 (en) Novel process
GB9826178D0 (en) Novel process
GB9817195D0 (en) Novel process
GB9828779D0 (en) Novel process
GB9806786D0 (en) Novel process
GB9828780D0 (en) Novel process
GB9828767D0 (en) Novel process
GB9817159D0 (en) Novel process
GB9813269D0 (en) Novel process
GB9826182D0 (en) Novel process
GB9826176D0 (en) Novel process
GB9812016D0 (en) Novel process
GB9816027D0 (en) Novel process
GB9805579D0 (en) Novel process
GB9807834D0 (en) Novel process
GB9822164D0 (en) Novel process

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)